Systematic review examines tumor microenvironment mechanisms in lung cancer brain metastases
New brain strategies target lung cancer before it spreads
This systematic review explores the complex mechanisms driving brain metastasis in patients with lung cancer. The authors synthesize how int…
Doctors are finding clever new ways to fight lung cancer that has spread to the brain without breaking the body's natural barriers
Higher Planetary Health Diet Index associated with reduced lung cancer incidence in cohort
Eating a planetary health diet lowers lung cancer risk by 29 percent in a large study.
This prospective cohort study analyzed 106,542 participants of the PLCO Cancer Screening Trial over 8.8 years. Participants in the highest q…
A new study shows that following a planetary health diet lowers lung cancer risk by 29 percent compared to the lowest intake levels.
Narrative review discusses eosinophil abundance associations with lung cancer prognosis and immunotherapy response
High eosinophil counts in lung cancer tumors may signal better responses to immune therapy.
This narrative review examines eosinophil abundance in tumor tissues and peripheral blood among lung cancer patients. Authors report associa…
Elevated eosinophil counts in lung cancer patients often link to improved responses to immune checkpoint inhibitors, though their exact role…
NTCP Models Underestimate Radiation Pneumonitis Risk in Lung Cancer Patients
New tool better predicts lung damage from radiation therapy
This cohort study of 580 lung cancer patients found that QUANTEC and Appelt NTCP models systematically underestimated radiation pneumonitis …
A new risk model more accurately predicts lung injury after modern radiation therapy for lung cancer, helping doctors tailor safer treatment…
Inflammatory indicators associated with increased lung cancer incidence in Kailuan cohort
High Inflammatory Markers Linked to Higher Lung Cancer Risk in Older Adults
This cohort study included 99,925 participants from the Kailuan cohort with a mean follow-up of 14.85 years. Higher levels of inflammatory i…
Tracking inflammation markers over nearly 15 years shows higher levels are linked to increased risk of developing lung cancer, especially in…
CIPHER model predicts immune checkpoint inhibitor pneumonitis risk in non-small cell lung cancer patients
Lung Scans Can Now Predict Dangerous Side Effect Before Treatment
This cohort study evaluated a CIPHER model versus classical radiomic models for predicting immune checkpoint inhibitor-induced pneumonitis i…
This tool could help doctors protect patients before a serious side effect strikes.
Preclinical deep learning framework shows improved dose prediction for unseen cancer sites
A Heavy Burden on Doctors
This is a preclinical development study of a deep learning framework for radiotherapy dose prediction. The framework performed comparably to…
A new AI tool can plan radiation doses for many different cancers at once.
Phase III trial indicates ultra-low-dose nivolumab may improve survival over chemotherapy in advanced solid tumors
A Tiny Dose of This Cancer Drug Is Outperforming Chemo
This Phase III randomized trial evaluated ultra-low-dose nivolumab against standard chemotherapy in patients with advanced solid tumors prog…
Giving a much smaller dose of a powerful cancer drug can extend life with fewer side effects, making treatment more tolerable and accessible…
Systematic review and meta-analysis of nurse-led shared decision-making for lung cancer screening uptake.
Nurse-led conversations may help high-risk lung cancer patients choose low-dose CT scans.
This systematic review and meta-analysis evaluates nurse-led shared decision-making in high-risk lung cancer populations. It reports LDCT up…
A review of 13,608 patients found nurse-led shared decision-making increased willingness to participate in lung cancer screening, with most …
Review of 68Ga-Pentixafor PET/CT Utility in Lung Cancer Diagnosis and Management
Lung Scans Get Smarter With New Imaging Tool
This narrative review examines the utility of 68Ga-Pentixafor PET/CT in patients with lung cancer. The authors synthesize evidence regarding…
You wake up, cough again — just like the past few weeks.
Narrative review summarizes bispecific antibodies and CAR T-cell therapy for advanced lung cancer.
New Lung Cancer Tools Are Coming Soon
This narrative review evaluates bispecific antibodies and chimeric antigen receptor (CAR) T-cell therapy for patients with advanced non–smal…
Imagine a soldier who can fight two enemies at once.
Narrative review discusses immune checkpoint inhibitors in lung cancer patients
New Hope for Lung Cancer Patients
This narrative review examines immune checkpoint inhibitors (ICIs), including PD-1/PD-L1 and CTLA-4 inhibitors, for patients with lung cance…
Lung cancer patients now have a fighting chance as new medicines help the body's own immune system attack tumors instead of just killing cel…